NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients-Reference-Cited by-同舟云学术

NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients

Published:2012-10-01 Issue:11 Volume:42 Page:3038-3048
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Harari Alexandre¹²,Rozot Virginie¹,Cavassini Matthias³,Enders Felicitas Bellutti¹,Vigano Selena¹,Tapia Gonzalo¹,Castro Erika¹,Burnet Séverine¹,Lange Joep⁴,Moog Christiane⁵,Garin Daniel⁶,Costagliola Dominique⁷⁸,Autran Brigitte⁸,Pantaleo Giuseppe¹²,Bart Pierre-Alexandre¹

Affiliation:

1. Division of Immunology and Allergy; Lausanne University Hospital; Lausanne Switzerland

2. Swiss Vaccine Research Institute; Lausanne Switzerland

3. Division of Infectious Diseases; Lausanne University Hospital; Lausanne Switzerland

4. Department of Global Health; Academic Medicial Center; Amsterdam Institute for Global Health and Development; University of Amsterdam; The Netherlands

5. INSERM Unit 748; Université de Strasbourg, Strasbourg, France

6. Laboratoire de Virologie; IRBA; Grenoble France

7. UPMC Université de Paris 06 and INSERM; UMRS 943 Paris France

8. Cellular Immunology Laboratory; Pierre and Marie Curie University; INSERM UMRS 543, Pitié-Salpêtrière Hospital; Paris France

Funder

European Union TheraVac Demonstration project

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication;Chun;AIDS,2010